CITIUS ONCOLOGY, INC. Proceeds from Issuance Initial Public Offering
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2025-12-23
- CITIUS ONCOLOGY, INC. proceeds from issuance initial public offering for the quarter ending 2024-06-30 was $0.00.
- CITIUS ONCOLOGY, INC. proceeds from issuance initial public offering for the quarter ending 2024-03-31 was $67.32M.
- CITIUS ONCOLOGY, INC. proceeds from issuance initial public offering for fiscal 2023 was $67.32M.
| Period end | Proceeds from Issuance Initial Public Offering | Proceeds from Issuance Initial Public Offering as first filed | Proceeds from Issuance Initial Public Offering 0 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|---|
| 2025-07-17 | $7.55M 10-K · filed 2025-12-23 | $7.44M 10-Q · filed 2025-08-12 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $67.32M 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | $67.32M 10-Q · filed 2024-05-20 | |||||
| 2023-12-31 | $67.32M 10-K · filed 2024-04-16 | |||||
| 2022-10-18 | $67.32M 10-Q · filed 2024-08-09 | $67.32M 10-Q · filed 2024-05-20 |